FDA Inspection 1236258 — AX Pharmaceutical Corporation
The FDA completed an inspection of AX Pharmaceutical Corporation on Mar 5, 2024 in Concord. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 5, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Concord (Canada)